Related Experiment Video
Updated: Apr 29, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Biochemical defects in minor spliceosome function in the developmental disorder MOPD I
Faegheh Jafarifar1, Rosemary C Dietrich1, James M Hiznay1
1Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Abstract:
Biallelic mutations of the human RNU4ATAC gene, which codes for the minor spliceosomal U4atac snRNA, cause the developmental disorder, MOPD I/TALS. To date, nine separate mutations in RNU4ATAC have been identified in MOPD I patients. Evidence suggests that all of these mutations lead to abrogation of U4atac snRNA function and impaired minor intron splicing. However, the molecular basis of these effects is unknown. Here, we use a variety of in vitro and in vivo assays to address this question. We find that only one mutation, 124G>A, leads to significantly reduced expression of U4atac snRNA, whereas four mutations, 30G>A, 50G>A, 50G>C and 51G>A, show impaired binding of essential protein components of the U4atac/U6atac di-snRNP in vitro and in vivo. Analysis of MOPD I patient fibroblasts and iPS cells homozygous for the most common mutation, 51G>A, shows reduced levels of the U4atac/U6atac.U5 tri-snRNP complex as determined by glycerol gradient sedimentation and immunoprecipitation. In this report, we establish a mechanistic basis for MOPD I disease and show that the inefficient splicing of genes containing U12-dependent introns in patient cells is due to defects in minor tri-snRNP formation, and the MOPD I-associated RNU4ATAC mutations can affect multiple facets of minor snRNA function.
Insights
Mutations in the RNU4ATAC gene cause MOPD I by impairing the U4atac snRNA
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- Biallelic mutations in the RNU4ATAC gene cause MOPD I/TALS, a developmental disorder.
- Nine RNU4ATAC mutations are known in MOPD I patients, all potentially affecting U4atac snRNA function and minor intron splicing.
- The precise molecular mechanisms underlying these effects remain unclear.
Purpose of the Study:
- To elucidate the molecular basis of MOPD I/TALS caused by RNU4ATAC mutations.
- To investigate how specific RNU4ATAC mutations impact U4atac snRNA expression, protein binding, and complex formation.
- To understand the link between these molecular defects and impaired minor intron splicing in patient cells.
Main Methods:
- In vitro and in vivo assays to assess U4atac snRNA expression and protein binding.
- Analysis of MOPD I patient fibroblasts and induced pluripotent stem cells (iPSCs).
- Glycerol gradient sedimentation and immunoprecipitation to study snRNP complex formation.
Main Results:
- One mutation (124G>A) significantly reduced U4atac snRNA expression.
- Four mutations (30G>A, 50G>A, 50G>C, 51G>A) impaired the binding of essential proteins to U4atac snRNA.
- Cells with the common 51G>A mutation showed reduced levels of the U4atac/U6atac.U5 tri-snRNP complex.
- Inefficient splicing of U12-dependent introns in patient cells was linked to defects in minor tri-snRNP formation.
Conclusions:
- RNU4ATAC mutations disrupt multiple aspects of minor snRNA function, including expression, protein association, and complex assembly.
- Defects in minor tri-snRNP formation underlie the inefficient splicing observed in MOPD I patient cells.
- This study establishes a mechanistic basis for MOPD I/TALS, linking RNU4ATAC mutations to specific molecular defects in the minor spliceosome.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
RNA Splicing
ATP Synthase: Mechanism
Myasthenia Gravis ll: Pathophysiology
Lysosomal Hydrolases

